Nandrolone
Last updated: 17/08/2023
(Not known by any other names)
The following alerts are based on the data in the tables below. An absence of an alert does not imply the substance has no implications for human health, biodiversity or the environment but just that we do not have the data to form a judgement.
Environmental fate
Ecotoxicity
Human health
 
An anabolic steriod that has a variety of uses in veterinary medicine including the correction of negative nitroge nand calcium balance in debility and to aid healing and convalescence
-
1950, first synthesised
Cats, Dogs, Pigs
Isomeric
C₁₈H₂₆O₂
CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34
NPAGDVCDWIYMMC-IZPLOLCNSA-N
InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1
Yes
Cambridge Crystallographic Data Centre diagrams
Common Name
Relationship
Link
nandrolone
-
Hormone substitute, Anabolic steriod, Medicinal drug
Progesterone steroid
-
-
Synthetic
An androgen receptor agonist
[Androgen receptor, agonist]
434-22-0
207-101-0
-
-
-
QA14AB01
Alimentary tract & metabolism: Anabolic agents for systemic use
Yes - Group 4
No data
274.4
-
17β-hydroxy-19-nor-4-andro-sten-3-one
19-nortestosterone
USA Superlist DEA Schedule III; Evidence of use in third world countries
-
-
Laurabolin 25 mg/ml, solution for injection
Intervet UK Ltd
UK National authorisation
Prescription only medicine to be authorised by a veterinarian (POM-V)
Laurabolin 50 mg/ml, solution for injection
Intervet UK Ltd
UK National authorisation
Prescription only medicine to be authorised by a veterinarian (POM-V)
Usually supplied as an oil-based injectable solution
323
Moderate
-
-
-
122
-
-
-
-
-
-
-
-
-
-
4.17 X 1002
Calculated
-
2.62
Low
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
In ethanol: 241nm = 17000
L3 L = Pesticide manuals and hard copy reference books / other sources 3 = Unverified data of known source
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Not expected to undergo hydrolysis
-
-
-
-
-
-
Soil adsorption and mobility
-
Slightly mobile
630
Estimated
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Known soil and groundwater metabolites
None
19-norandrosterone
19-NA
Human (Urine)
-
-
19-noretiocholanolene
19-NE
Human (Urine)
-
-
5-dihydro-19-nortestosterone
dihydronandrolone
Human
-
5-alpha reductase
Terrestrial ecotoxicology
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
HUMAN HEALTH AND PROTECTION
High (class III)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
May be absorbed through the skin
Rapidly excreted via the urine and faeces
-
Carcinogen
Endocrine disruptor
XNo, known not to cause a problem
A0 A = Chromosome aberration (EFSA database) 0 = No data
; B0 B = DNA damage/repair (EFSA database) 0 = No data
; C0 C = Gene mutation (EFSA database) 0 = No data
; D0 D = Genome mutation (EFSA database) 0 = No data
; E0 E = Unspecified genotoxicity type (miscellaneous data source) 0 = No data
No data found
Reproduction / development effects
Acetyl cholinesterase inhibitor
Neurotoxicant
✓Yes, known to cause a problem
No data found
No data found
Respiratory tract irritant
Skin irritant
Skin sensitiser
✓Yes, known to cause a problem
✓Yes, known to cause a problem
No data found
Eye irritant
Phototoxicant
 
✓Yes, known to cause a problem
No data found
 
May cause gastrointestinal problems May cause headache, unusual tiredness, dizziness, trouble sleeping, habituation, excitation and depression
No information available
-
Not listed (Not listed)
-
-
-
nandrolone
-
-
-
-
nandrolona
-
-
-
-
-
-
Record last updated:
17/08/2023
Contact:
aeru@herts.ac.uk
Please cite as:
Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal , 22 (4), 1050-1064. DOI: 10.1080/10807039.2015.1133242